115 related articles for article (PubMed ID: 37603378)
21. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
22. Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel.
Gangapuram M; Mazzio EA; Redda KK; Soliman KFA
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299315
[TBL] [Abstract][Full Text] [Related]
23. Orally bioavailable tubulin antagonists for paclitaxel-refractory cancer.
Li CM; Lu Y; Chen J; Costello TA; Narayanan R; Dalton MN; Snyder LM; Ahn S; Li W; Miller DD; Dalton JT
Pharm Res; 2012 Nov; 29(11):3053-63. PubMed ID: 22760659
[TBL] [Abstract][Full Text] [Related]
24. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
[TBL] [Abstract][Full Text] [Related]
25. Co-Inhibition of P-gp and Hsp90 by an Isatin-Derived Compound Contributes to the Increase of the Chemosensitivity of MCF7/ADR-Resistant Cells to Doxorubicin.
Abdalla AN; Di Stefano M; Poli G; Tuccinardi T; Bader A; Vassallo A; Abdallah ME; El-Readi MZ; Refaat B; Algarni AS; Ahmad R; Alkahtani HM; Abdel-Aziz AA; El-Azab AS; Alqathama A
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011321
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.
Imamura Y; Mukohara T; Shimono Y; Funakoshi Y; Chayahara N; Toyoda M; Kiyota N; Takao S; Kono S; Nakatsura T; Minami H
Oncol Rep; 2015 Apr; 33(4):1837-43. PubMed ID: 25634491
[TBL] [Abstract][Full Text] [Related]
27. TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters.
Schneiderman RS; Shmueli E; Kirson ED; Palti Y
BMC Cancer; 2010 May; 10():229. PubMed ID: 20492723
[TBL] [Abstract][Full Text] [Related]
28. Development and verification of a three-dimensional (3D) breast cancer tumor model composed of circulating tumor cell (CTC) subsets.
Anil-Inevi M; Sağlam-Metiner P; Kabak EC; Gulce-Iz S
Mol Biol Rep; 2020 Jan; 47(1):97-109. PubMed ID: 31583566
[TBL] [Abstract][Full Text] [Related]
29. Role of intercellular communications in breast cancer multicellular tumor spheroids after chemotherapy.
Oktem G; Bilir A; Ayla S; Yavasoglu A; Goksel G; Saydam G; Uysal A
Oncol Res; 2006; 16(5):225-33. PubMed ID: 17294803
[TBL] [Abstract][Full Text] [Related]
30. Design, Synthesis and Biological Evaluation of 1H-1,2,3-Triazole-Linked-1H-Dibenzo[b,h]xanthenes as Inductors of ROS-Mediated Apoptosis in the Breast Cancer Cell Line MCF-7.
Bortolot CS; da S M Forezi L; Marra RKF; Reis MIP; Sá BVFE; Filho RI; Ghasemishahrestani Z; Sola-Penna M; Zancan P; Ferreira VF; de C da Silva F
Med Chem; 2019; 15(2):119-129. PubMed ID: 29792156
[TBL] [Abstract][Full Text] [Related]
31. Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
Balsa LM; Ferraresi-Curotto V; Lavecchia MJ; Echeverría GA; Piro OE; García-Tojal J; Pis-Diez R; González-Baró AC; León IE
Dalton Trans; 2021 Jul; 50(28):9812-9826. PubMed ID: 34190268
[TBL] [Abstract][Full Text] [Related]
32. AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies.
Godugu C; Patel AR; Desai U; Andey T; Sams A; Singh M
PLoS One; 2013; 8(1):e53708. PubMed ID: 23349734
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells.
Jang JY; Kim MK; Jeon YK; Joung YK; Park KD; Kim CW
Exp Mol Med; 2012 Apr; 44(4):251-9. PubMed ID: 22198296
[TBL] [Abstract][Full Text] [Related]
34. Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide.
Uematsu N; Zhao Y; Kiyomi A; Yuan BO; Onda K; Tanaka S; Sugiyama K; Sugiura M; Takagi N; Hayakawa A; Hirano T
Anticancer Res; 2018 Apr; 38(4):2101-2108. PubMed ID: 29599328
[TBL] [Abstract][Full Text] [Related]
35. New (3-(1
Mullagiri K; Nayak VL; Sunkari S; Mani GS; Guggilapu SD; Nagaraju B; Alarifi A; Kamal A
Medchemcomm; 2018 Feb; 9(2):275-281. PubMed ID: 30108921
[TBL] [Abstract][Full Text] [Related]
36. Arsenic Disulfide Combined with L-Buthionine-(S, R)-Sulfoximine Induces Synergistic Antitumor Effects in Two-Dimensional and Three-Dimensional Models of MCF-7 Breast Carcinoma Cells.
Zhao Y; Tanaka S; Yuan B; Sugiyama K; Onda K; Kiyomi A; Takagi N; Sugiura M; Hirano T
Am J Chin Med; 2019; 47(5):1149-1170. PubMed ID: 31311297
[TBL] [Abstract][Full Text] [Related]
37. The Cisplatin, 5-fluorouracil, Irinotecan, and Gemcitabine Treatment in Resistant 2D and 3D Model Triple Negative Breast Cancer Cell Line: ABCG2 Expression Data.
Ata FK; Yalcin S
Anticancer Agents Med Chem; 2022; 22(2):371-377. PubMed ID: 34315389
[TBL] [Abstract][Full Text] [Related]
38. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells.
Prados J; Melguizo C; Rama AR; Ortiz R; Segura A; Boulaiz H; Vélez C; Caba O; Ramos JL; Aránega A
Cancer Chemother Pharmacol; 2010 May; 66(1):69-78. PubMed ID: 19771430
[TBL] [Abstract][Full Text] [Related]
39. Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models.
Aouad P; Saikali M; Abdel-Samad R; Fostok S; El-Houjeiri L; Pisano C; Talhouk R; Darwiche N
Anticancer Drugs; 2017 Aug; 28(7):757-770. PubMed ID: 28471809
[TBL] [Abstract][Full Text] [Related]
40. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
